Barclays raised the firm’s price target on Zoetis (ZTS) to $244 from $242 and keeps an Overweight rating on the shares. The company’s 2025 outlook “was not as bad as initial stock reaction made it look,” the analyst tells investors in a research note. The firm is confident that Zoetis’s underlying fundamentals are still intact.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZTS: